Ads
related to: keytruda cancer drug- Side Effect Information
Learn More About Potential
Side Effects Here.
- Clinical Trials Results
Access Clinical Trial Results
and Information Here.
- Treatment Tips
Tips to Help You Before
and During Treatment.
- Official Patient Website
Learn About the Treatment Option
That May Be Right for You.
- Financial Support
Find Information on Financial
Support Programs Here.
- Patient Support
Utilize Patient Resources
to Help You Through Your Journey.
- Side Effect Information
Search results
ImmunityBio Advances On the Anktiva Front
Los Angeles Business Journal· 1 day agoImmunityBio Inc., the Culver City-based immunotherapy company founded by billionaire Patrick Soon-Shiong that last month won Food and Drug Administration approval for its ...
Merck stops skin cancer combination therapy testing in late-stage study
Reuters via Yahoo Finance· 1 day agoMay 13 (Reuters) - Merck said on Monday it had discontinued the arm of a late-stage study, which tested an experimental antibody-based drug with its blockbuster immunotherapy ...
Merck’s trial of KEYTRUDA regimen fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 4 days agoEarlier this month, Merck reported the final analysis findings from the Phase III KEYNOTE-811 trial...
Is Johnson & Johnson Stock A Better Pick Over Merck?
Forbes· 9 hours agoAlthough Merck trades at a higher valuation of 5.5x trailing revenues, compared to 4.2x for J&J, we think that this valuation gap will likely narrow over...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks· 1 day agoFree Report) recently announced that a late-stage study, seeking to expand the label of its cancer combination drug, Opdivo (nivolumab) and Yervoy (ipilimumab ...
Merck's endometrial cancer therapy fails trial
Reuters via Yahoo News· 5 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after...
...Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles...
The Yuma Sun· 4 days agoAethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced ...
Aethlon Medical Stock Surges In Pre-market On Positive Hemopurifier Trial Results
RTT News· 4 days agoIn pre-market activity on the Nasdaq, Aethlon shares were surging more than 101 percent to trade at $2.44. The company...clinical trials of the Hemopurifier in patients with solid tumors who ...
Merck's endometrial cancer therapy fails trial
AOL· 5 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after surgery ...
The doctor behind the next big thing in cancer treatment
CNN via Yahoo News· 5 days agoDr Catherine Wu’s research has laid the scientific foundation for the development of cancer vaccines...
Ads
related to: keytruda cancer drug
